The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.
CONCLUSION: Based on the reviewed literature, allopurinol appears to be a promising therapy to improve vascular function and reduce disability in patients who have had a stroke. The benefits seen are in combination with current standard of care treatments with aspirin and lipid-lowering therapy. Larger trials are necessary to better understand the role of allopurinol in patients with history of stroke.
PMID: 28933307 [PubMed - as supplied by publisher]
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Britnell SR, Chillari KA, Brown JN Tags: Curr Vasc Pharmacol Source Type: research
More News: Accidents | Allopurinol | Aspirin | Cardiology | Cardiovascular | Disability | Drugs & Pharmacology | Gastroenterology | Gout | Headache | Heart | Migraine | Stroke | Study